CDC42
MOLECULAR TARGETcell division cycle 42
CDC42 (cell division cycle 42) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CDC42
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | sanguinarium chloride | 2.56 | 12 |
| 2 | casin | 0.69 | 1 |
About CDC42 as a Drug Target
CDC42 (cell division cycle 42) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented CDC42 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CDC42 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.